|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-17
|
|
pubmed:abstractText |
Despite a decreased incidence of AIDS-related Kaposi's sarcoma (KS) due to the advent of highly active antiretroviral therapy, approximately 15% of AIDS patients still develop AIDS-related KS. This study evaluated the clinical benefit, tumor response, and safety of pegylated liposomal doxorubicin for the treatment of AIDS-related KS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1083-7159
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
114-23
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:17227906-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:17227906-Adult,
pubmed-meshheading:17227906-Aged,
pubmed-meshheading:17227906-Asthenia,
pubmed-meshheading:17227906-Double-Blind Method,
pubmed-meshheading:17227906-Doxorubicin,
pubmed-meshheading:17227906-Female,
pubmed-meshheading:17227906-Humans,
pubmed-meshheading:17227906-Male,
pubmed-meshheading:17227906-Middle Aged,
pubmed-meshheading:17227906-Nausea,
pubmed-meshheading:17227906-Neutropenia,
pubmed-meshheading:17227906-Polyethylene Glycols,
pubmed-meshheading:17227906-Safety,
pubmed-meshheading:17227906-Sarcoma, Kaposi,
pubmed-meshheading:17227906-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
|
|
pubmed:affiliation |
Lahey Clinic, Burlington, Massachusetts, USA. timothy.p.cooley@lahey.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
